Podcast: Autonomous labs redefine the role of biopharma researchers - Pharmaceutical Technology

Ginkgo Bioworks CEO Jason Kelly discusses the company’s work on autonomous labs and their impact on biopharma R&D. Ginkgo Bioworks CEO Jason Kelly discusses the company’s work on autonomous labs and their impact on biopharma R&D. With the rise of autonomous labs in biopharma, the role of human researchers comes under question. Photo by onurdongel/E+ via Getty Images. Advances in robotics and artificial intelligence (AI) are leading to a rise of autonomous biopharma labs—entities that can undertake biomedical research and development (R&D) with greater precision, consistency, and efficiency. Broadly, autonomous labs are comprised of automated machinery—self-loading bioreactors, robotic arms—guided by…

Source: Pharmaceutical Technology